Humana Inc. to Present at the Barclays Global Healthcare Conference

Thu Mar 7, 2013 2:15pm EST

* Reuters is not responsible for the content in this press release.

LOUISVILLE, Ky.--(Business Wire)--
Humana Inc. (NYSE: HUM) announced today that James H. Bloem, Senior Vice
President, Chief Financial Officer and Treasurer will make a presentation to
investors at the Barclays Global Healthcare Conference on Wednesday, March 13,
2013, at 9:00 a.m. eastern time. 

A live audio webcast of the presentation along with the accompanying slides will
be available via Humana`s Investor Relations page at The company
suggests webcast participants sign on approximately 15 minutes in advance of the
presentation to allow time to run a system test and download any free software
needed for access purposes. 

About Humana

Humana Inc., headquartered in Louisville, Kentucky, is a leading health care
company that offers a wide range of insurance products and health and wellness
services that incorporate an integrated approach to lifelong well-being. By
leveraging the strengths of its core businesses, Humana believes it can better
explore opportunities for existing and emerging adjacencies in health care that
can further enhance wellness opportunities for the millions of people across the
nation with whom the company has relationships. 

More information regarding Humana is available to investors via the Investor
Relations page of the company`s web site at, including copies

* Annual reports to stockholders; 
* Securities and Exchange Commission filings; 
* Most recent investor conference presentations; 
* Quarterly earnings news releases; 
* Replays of most recent earnings release conference calls; 
* Calendar of events (including upcoming earnings conference call dates and
times, as well as planned interaction with research analysts and institutional
* Corporate Governance information.

Humana Inc.
Investor Relations:
Regina Nethery, 502-580-3644
Corporate Communications:
Tom Noland, 502-580-3674

Copyright Business Wire 2013

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.